EFFECT OF DADIMADI GHRITA IN GARBHINI PANDU (ANAEMIA IN PREGNANCY)
DOI:
https://doi.org/10.70066/jahm.v2i3.157Keywords:
Dadimadi ghrita, Garbhini pandu, anaemia in pregnancyAbstract
Background: Every woman has the innate desire to experience the joys of motherhood. She is centre
of the ‘supraja-nirmiti’ (creation of healthy progeny). Woman has the unmatched role in creation,
preservation, nutrition of foetus. Ayurveda has aim to produce ‘supraja’ (healthy progeny) and not just
‘praja’ (progeny). The aim of any parent is to bear and nurture a healthy, capable child who can face
the pressures of our increasingly complex lifestyles.Anaemia either directly or indirectly contributes to
about 20 % of maternal deaths in the third world countries.
Aims and Objectives: To study the efficacy of dadimadi ghrita for treating garbhini pandu (anaemia in
pregnancy)
Methods and materials: Total 35 subjects suffering from anaemia in pregnancy were selected.
Dadimadi ghrita with dosage of10 ml was administered orally, at morning empty stomach with a cup of
warm water for 30 days. This was open labelled randomized uncontrolled clinical trial.
Results: Clinical observations in general symptoms of garbhini pandu (anaemia in pregnancy) have
revealed that percentage of relief, out of 35 subjects, 16 subjects have up to 51-75 % relief followed by
8 subjects up to 76-100 % and then 11 subjects up to 26-50 %. About Hb %, there was difference of 1
gm% in 15(42.86%), up to 1.5 gm% in10(28.57%), up to 0.5 gm% in 5(14.28%), more than 2 gm% in
3(8.57%).
Conclusion:This study has revealed that dadimadi ghrita has good effect on anaemia in pregnancy. As
well this drug has illustrated good effect on agni (digestive power) and nourishment of pregnant
woman without any side effects to foetus and pregnant woman.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 POURNIMA S. ARANKALLE
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The author(s) will retain copyright and permit the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that permits others to share the work with an acknowledgment of the author and initial publication in this journal.
The entire contents of the JAHM are protected under Indian and international copyrights. The Journal, however, allows free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, perform and display the work publicly and to make and distribute works in any online website for any non-commercial purpose, subject to proper attribution of authorship and ownership of the rights. The journal also permits the right to make small numbers of printed copies for their personal non-commercial use under Creative Commons Attribution-Noncommercial-Share Alike 4.0 License.
In case of JAHM does not publish said work, the author(s) will be so notified and all rights assigned hereunder will be given back to the author(s).
All accepted works should not be published anywhere without prior written permission from JAHM. The author(s) hereby declare that they are sole author(s) of the work, that all authors have contributed and agree with the content and conclusions of the work, that the work is original, and does not infringe upon any copyright, propriety, or personal right of any third party, and that no part of it nor any work has been submitted to another journal.
